期刊文献+

血清肝细胞生长因子水平与乳腺癌临床病理特征的关系 被引量:1

Relationship between the serum levels of hepatocyte growth factor and clinicopathological characteristics of breast cancer
下载PDF
导出
摘要 目的探讨血清肝细胞生长因子(HGF)水平与乳腺癌临床病理特征的关系及临床意义。方法应用酶链免疫吸附法检测100例可手术乳腺癌患者治疗前的血清HGF水平,比较年龄、雌激素受体表达情况、肿瘤大小、组织学分级、淋巴结状况及TNM分期与HGF关系。结果血清肝细胞生长因子与乳腺癌淋巴结状况、临床分期及组织学分级有关(P<0.05),而与患者年龄、肿瘤大小及雌激素水平无关(P>0.05)。结论血清肝细胞生长因子可能在乳腺癌的发生发展中起重要作用,可能是乳腺癌预后的独立指标。 Objective To investigate the relationship between the serum levels of hepatoeyte growth factor (HGF) and clinicopathological characteristics of breast cancer . Methods The serum HGF levels of 100 patients with breast cancer were measured by enzyme linked immunosorbent assay before treatment and the relationship between changes in serum HGF levels and age, expressions of estradiol receptor, tumor size, histologie grade, lymphonodus metastasis and TNM stage were analyzed. Results The serum HGF levels were significantly correlated with lymphonodus metastasis, histologie grade and TNM stage ( P 〈 O. 05 ), but it was insignificantly correlated with ages, tumor size and ER state ( P 〉 0.05). Conclusion The serum HGF may play an important role in the carcinogenesis and progression of the breast cancer, and HGF may be an independent markers of prognosis.
出处 《新乡医学院学报》 CAS 2009年第4期388-390,共3页 Journal of Xinxiang Medical University
关键词 乳腺癌 肝细胞生长因子 酶链免疫吸附法 breast cancer hepatocyte growth factor enzyme linked immunosorbent assay
  • 相关文献

参考文献8

  • 1沈振宙,邵志敏.乳腺肿瘤学[M].上海:上海科学技术出版社,2005.59-68.
  • 2于冀洋,朱光华,史青,何威逊.肝细胞生长因子与转化生长因子-β在肾脏病患儿肾组织中的表达[J].实用儿科临床杂志,2008,23(17):1346-1348. 被引量:3
  • 3刘洪,胡宝金,傅睿,邹音,柯江维.原发性肾病综合征患儿肝细胞生长因子及其受体的表达特征[J].实用儿科临床杂志,2009,24(5):345-347. 被引量:2
  • 4Rubin JS, Chan AM, Bottaro DP, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor[ J ]. Proc Natl Acad Sci USA, 1991,88 ( 2 ) :415- 419.
  • 5Yamashita J,Ogawa M, Yamashita S ,et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer [ J ]. Cancer Res, 1994,54 (7) : 1630-1633.
  • 6Eichbaum MH,de Rossi TM,Kaul S,et al. Serum levels of hepatocyte growth factor scatter factor in patients with liver metastases from breast cancer[J]. Tumour Biol,2007,28(1) :36-44.
  • 7Sheen-Chen SM, Liu YW, Eng HL, et al. Serum levels of hepatocyte growth factor in patients with breast cancer [ J ]. Cancer Epidemiolog'y Biomarkers & Prevention , 2005 ,14 ( 3 ) :715-717.
  • 8Pruefer FG, Unger-Saldana K, Mohamier L, et al. Tumor HGF lacks prognostic significance in mexican breast cancer patients [ J ]. J Exp Clin Cancer Res,2006,25 (3) :357-364.

二级参考文献25

  • 1薛痕,樊均明,陈亮,李孜,胡章学,刘先蓉.肝细胞生长因子负性调控细胞转分化在肾间质纤维化中的作用[J].中华肾脏病杂志,2005,21(8):458-463. 被引量:27
  • 2李暖,陈新德,杨达胜,赵德安,毕凌云.肝细胞生长因子在大鼠肾小管间质纤维化中的表达及意义[J].新乡医学院学报,2006,23(5):472-474. 被引量:7
  • 3Giannopoulou M, Dai C, Tan X, et al. Hepatocyte growth factor exerts its anti - inflammatory action by disrupting nuclear factor - kappaB signaling [ J ]. Am J Pathol,2008,173 ( 1 ) :30 - 41.
  • 4Gong R, Rifai A, Dworkin LD. Anti - inflammatory effect of hepatocyte growth factor in chronic kidney disease:Targeting the inflamed vascular endothelium [ J ]. J Am Soc Nephrol ,2006 ,17 ( 9 ) :2464 - 2473.
  • 5Zachow R, Uzumcu M. The hepatocyte growth factor system as a regulator of female and male gonadal function[ J]. J Endocrinol,2007,195 ( 3 ) : 359 - 371.
  • 6Ohnishi H, Mizuno S, Nakamura T. Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow - derived cell engraftment in acute renal failure [ J ]. Am J Physiol Renal Physiol ,2008 ,294 ( 2 ) : 326 - 335.
  • 7Gong R. Multi - target anti - inflammatory action of hepatocyte growth factor [ J ]. Curr Opin lnvestig Drugs,2008,9 ( 11 ) : 1163 - 1170.
  • 8Homsi E, Janino P, Biswas SK, et al. Attenuation of glycerol - induced acute kidney injury- by previous partial hepatectomy: Role of hepatoeytc growth factor/c - met axis in tubular protection[ J]. Nephron Exp Neph- rol,2007,107(3) : 95 - 106.
  • 9Mizuno S, Matsumoto K, Nakamura T. HGF as a renotrophic and anti - fibrotic regulator in chronic renal disease [ J]. Front Biosci, 2008,13 : 7072 - 7O86.
  • 10Abe S, Amagaski Y, Lyori S, et al. Significance of tubulointerstitial lesions in biopsy specimens glomerulonephritic patients [ J ]. Am J Nephrol, 1989,9( 1 ) :30 -37.

共引文献9

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部